Researchers at the Paul Scherrer Institute (PSI) have recently achieved a significant advancement in early cancer detection and monitoring. This innovative method employs artificial intelligence (AI) to analyze changes in the nuclei of specific blood cells, offering a promising new tool for cancer diagnosis and treatment efficacy assessment. AI-Powered cancer detection of a new hope